Related Experiment Video
Updated: May 1, 2026
15:17
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
14.0K
How pharmacists would design and implement a community pharmacy-based colorectal cancer screening program
Austin R Waters1,2, Katherine Meehan3, Dana L Atkins4
1Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27510, USA.
Preventive Oncology & Epidemiology
|June 17, 2024
Summary
Community pharmacies can improve equitable access to colorectal cancer (CRC) screening by distributing fecal immunochemical tests (FIT). Pharmacists are receptive to this role, provided implementation considers their workflow and offers necessary support for patient care coordination.
Area of Science:
- Implementation Science
- Public Health
- Pharmacy Practice
Background:
- Community pharmacies offer accessible venues for health services.
- Integrating colorectal cancer (CRC) screening into pharmacies presents implementation challenges.
- Pharmacy-based screening can potentially improve health equity.
Purpose of the Study:
- To explore community pharmacists' perspectives on distributing fecal immunochemical tests (FIT) for CRC screening.
- To identify facilitators and barriers to implementing pharmacy-based CRC screening programs.
Main Methods:
- 23 semi-structured interviews with community pharmacists in Washington and North Carolina.
- Analysis guided by the Consolidated Framework for Implementation Research (CFIR).
Main Results:
- Pharmacists viewed FIT distribution as compatible with their practice.
- Knowledge of eligibility criteria varied, but pharmacists felt comfortable screening.
- Essential design features include standardized criteria, patient education, and continuing education.
- Pharmacists suggested adapting EHR systems for reminders and expressed a need for improved PCP communication.
Conclusions:
- Pharmacy-based CRC screening is feasible when programs align with pharmacists' knowledge and context.
- Addressing multi-level factors is crucial for successful implementation of FIT delivery in pharmacies.
Related Concept Videos
01:30Primary Healthcare Services
3.1K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
3.1K
01:30Preventive Healthcare Services
2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
01:25Endoscopic Procedures II: Colonoscopy
1.3K
The colon, or large intestine, is the final segment of the digestive system. Its primary functions include absorbing water and vitamins produced by gut bacteria and transforming waste from liquid to solid to form stool. In adults, the large intestine is approximately 5 feet long and consists of four main sections:
1.3K
01:28Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
01:29Pharmacogenetics and Pharmacogenomics: Overview
253
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121